iNtRON Biotechnology (XKRX:048530) Change In Other Working Capital : ₩-119 Mil (TTM As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is iNtRON Biotechnology Change In Other Working Capital?

iNtRON Biotechnology's Change In Other Working Capital for the quarter that ended in Mar. 2025 was ₩3,197 Mil. It means iNtRON Biotechnology's Other Working Capital increased by ₩3,197 Mil from Dec. 2024 to Mar. 2025 .

iNtRON Biotechnology's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ₩-186 Mil. It means iNtRON Biotechnology's Other Working Capital declined by ₩186 Mil from Dec. 2023 to Dec. 2024 .

iNtRON Biotechnology Change In Other Working Capital Historical Data

The historical data trend for iNtRON Biotechnology's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iNtRON Biotechnology Change In Other Working Capital Chart

iNtRON Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

-317.63

160.27

-3,048.92

-1,277.01

-185.80

iNtRON Biotechnology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															3,130.54	-3,217.74	-278.84	180.25	3,197.05

iNtRON Biotechnology Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-119 Mil.

iNtRON Biotechnology Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of iNtRON Biotechnology's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

iNtRON Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iNtRON Biotechnology Inc (XKRX:048530) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

137, Sagimakgol-ro, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR

Website

http://www.intron.co.kr

iNtRON Biotechnology Inc is a Korea-based company principally engaged in the biotechnology industry. It develops, manufactures, and commercializes drugs for the treatment of infectious diseases. It is contributing to national health and national prevention through several (molecular) diagnostic products such as swine flu, VRE super bacteria, food poisoning, avian influenza and foot, and mouth disease. In addition, it is also engaged in the operation of a veterinary antibiotic alternative business and new biopharmaceuticals development business.

iNtRON Biotechnology Headlines

No Headlines